COVID19 Antibodies

COVID Losing Its Own Genes To Survive Against Antibodies

Again and again, the new coronavirus has sloughed off small chunks of its genome, leading to changes in a viral protein that is frequently targeted by antibodies, says a new report published in nature.

  • SARS-CoV-2 emerged from a yet-to-be defined animal reservoir and initiated a pandemic in 2020.
  •  It has acquired limited adaptions, most notably the D614G substitution in the spike (S) glycoprotein.
  •  Humoral immunity to S glycoprotein appears to be the strongest correlate of protection and...

https://mfame.guru/covid-losing-its-own-genes-to-survive-against-antibodies/

COVID19 Virus To Infection – What Lies in the Genes

In a research paper published in Nature, Scientists chronicle the journey of the covid virus from genome to infectome, that’s how its genes became an infecting virulent gene. 

Today we are going to look into that analysis to better understand the virus.

How COVID19 Became an Infecting Virus?

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1 and probably originated either from bats or pangolins. 

SAR...

https://mfame.guru/covid19-virus-to-infection-what-lies-in-the-genes/

US President’s COVID Antibody Treatment Receives FDA Emergency Approval

According to a BBC report, the drug, developed by Regeneron, will be allowed for use in people who have tested positive for the virus and are at risk of severe illness.

Studies suggest the therapy is effective when administered early after diagnosis, the company says.

Emergency authorisation by the Food and Drug Administration (FDA) allows use of a treatment while studies are carried out to determine safety and effectiveness.



A similar drug made by Eli Lilly, another US pharmaceutical firm, was...

https://mfame.guru/us-presidents-covid-antibody-treatment-receives-fda-emergency-approval/

Antibodies Prevail in 91% of Recovered People, Says Covid 19 Research

  • A Covid 19 antibody study on the pandemic in Iceland published in the New England Journal of Medicine offers some evidence to dispel such fears.
  • The researchers have looked at serum samples from 30,576 individuals, using six different types of antibody testing.
  • The paper’s central findings are that, out of 1,797 tested people who’d recovered from Covid, 91.1% produced detectable levels of antibodies.
  • It is also too early so say whether these antibody findings will hold over a longer time...

https://mfame.guru/antibodies-prevail-in-91-of-recovered-people-says-covid-19-research/

Lab Designed COVID19 Antibodies Better Than Remdesivir

According to an article published in Science, while the world is transfixed by the high-stakes race to develop a COVID-19 vaccine, an equally crucial competition is heating up to produce targeted antibodies that could provide an instant immunity boost against the virus.

Targeted monoclonal anitbodies

Clinical trials of these monoclonal antibodies, which could both prevent and treat the disease, are already underway and could produce signs of efficacy in the next few months, perhaps ahead of...

https://mfame.guru/lab-designed-covid19-antibodies-better-than-remdesivir/

No Long Lasting Immunity To COVID19 Shows Studies on Recovered People

  • Although the corona relapse studies in the recovered patients are found to be faulty yet it may still be the case.
  • Scientists have now discovered that the coronavirus antibodies decline sharply over time.
  • The study conducted amongst recovered and asymptomatic people shows how quickly we can lose the immunity gained through viral exposure
  • Within weeks, sometimes days of release from hospitals, people show a decline in COVID19 antibody
  • This highlights why vaccines are important and we can’t rely...

https://mfame.guru/no-long-lasting-immunity-to-covid19-shows-studies-on-recovered-people/

[Watch] First Successful COVID19 Antibodies Production in Vaccine Trials!

In a major development in COVID19 Vaccine trials, Volunteers who received Moderna’s Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine, says a CNN report by Elizabeth Cohen, Senior Medical Correspondent of CNN.

Vaccine To Be Available By Next Year?

If future studies go well, the company’s vaccine could be available to the public as early as January, Dr. Tal Zaks, Moderna’s chief medical...

https://mfame.guru/watch-first-successful-covid19-antibodies-production-in-vaccine-trials/